GTx, Inc.

News and overview for GTx, Inc.

GTx reports financial results for the third quarter of 2009
News-Medical.Net | 15 days 14 hours 32 minutes ago
GTx, Inc. (Nasdaq: GTXI) today reported financial results for the third quarter of 2009. The net loss for the third quarter and nine months ended September 30, 2009 was $12.8 million and $35.4 million, respectively, compared with a net loss of $11.9 million and $37.9 million for the same periods in 2008. At September 30, 2009 GTx had cash, cash equivalents and short-term investments of $55.5 million.


GTx, Inc. Reports Third Quarter 2009 Corporate Results [Press Release]
Business Wire | 15 days 15 hours 51 minutes ago
GTx, Inc. (Nasdaq: GTXI) today reported financial results for the third quarter of 2009. The net loss for the third quarter and nine months ended September 30, 2009 was $12.8 million and $35.4 million, respectively, compared with a net loss of $11.9 million and $37.9 million for the same periods in 2008. At September 30, 2009 GTx had cash, cash equivalents and short-term investments of $55.5 million.


GTx Receives Complete Response Letter from FDA for Toremifene 80 mg New Drug Application [Press Release]
Business Wire | 22 days 14 hours 51 minutes ago
GTx, Inc. (NASDAQ: GTXI) today announced that it has received a Complete Response Letter issued by the United States Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for toremifene 80 mg to reduce fractures in men with prostate cancer receiving androgen deprivation therapy (ADT).


FDA issues a Complete Response Letter for GTx' toremifene NDA
News-Medical.Net | 22 days 13 hours 31 minutes ago
GTx, Inc. (NASDAQ: GTXI) today announced that it has received a Complete Response Letter issued by the United States Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for toremifene 80 mg to reduce fractures in men with prostate cancer receiving androgen deprivation therapy (ADT).


GTX Corp Secures $10 Million Financing Commitment From Institutional Investor [Press Release]
PRNewswire | 6 days 7 hours 36 minutes ago
...pricing formula. "We believe that GTX Corp's technology is extremely...the "better people finder" GTX Corp also owns and operates LOCiMOBILE, Inc www.locimobile.com which...marks, copy rights and URL's. GTX Corp is well positioned to capture...


GTx, Inc. Announces Third Quarter 2009 Corporate Results Conference Call and Webcast [Press Release]
Business Wire | 20 days 14 hours 51 minutes ago
GTx, Inc. (NASDAQ: GTXI) today announced that it will host a conference call and webcast to discuss the Company’s third quarter 2009 corporate results on Monday, November 9 at 9:00 a.m. Eastern. The call and webcast will follow the release of the third quarter 2009 results earlier that day.


GTX Corp Awarded Broad U.S. Patent for its Innovative Life Changing GPS Enabled Shoes [Press Release]
PRNewswire | 56 days 14 hours 18 minutes ago
...reissue patents along with GTX Corp's other utility...competitive advantage in GTX Corp's technological...with Aetrex Worldwide, Inc., a global leader in...better people finder" GTX Corp owns LOCiMOBILE, Inc which markets iPhone GPS...


GTx to Host Conference Call and Webcast to Provide Update on Status of Toremifene 80 mg New Drug Application [Press Release]
Business Wire | 25 days 7 hours 29 minutes ago
GTx, Inc. (NASDAQ: GTXI) today announced that it will host a conference call and webcast on Monday, November 2, 2009 to provide an update regarding the New Drug Application for toremifene 80 mg to reduce fractures in men with prostate cancer on androgen deprivation therapy.


GTX Corp and Kalika Group Sign Agreement to Deliver 2 Way GPS PLS Solutions to One-Quarter of the World's Population [Press Release]
PRNewswire | 69 days 11 hours 19 minutes ago
GTX Corp and Kalika Group Sign Agreement...American office in Baltimore, USA. GTX Corp (GTXO.OB) develops and integrates...being the "better people finder" GTX Corp owns and operates LOCiMOBILE, Inc. which develops Apps connecting friends...


GTx 3rd-quarter loss adds to setback for approval of new drug » The Commercial Appeal
Commercial Appeal (Memphis, Tenn.), The | 14 days 21 hours 43 minutes ago
Username * Don't have an account? Sign up for a new account


GTX Corp and BrickHouse Security Team to Protect the 2,000 Children Reported Missing Daily With GPS Personal Location Solutions [Press Release]
PRNewswire | 64 days 9 hours 19 minutes ago
...Now that we're working with GTX Corp I'm comforted to know that...to - missing child found GTX Corp (GTXO.OB) develops and...being the "better people finder" GTX Corp owns and operates LOCiMOBILE, Inc.(www.locimobile.com) which...


FDA finds deficiencies in GTx drug, stock tumbles
American City Business Journals | 21 days 18 hours 30 minutes ago
Memphis-based GTx Inc. has received a Complete Response Letter from the U.


Sysnet Forms Alliance With GTX Partners [Press Release]
PRNewswire | 41 days 3 hours 7 minutes ago
...its strategic partnership with GTX Partners LLC. Sysnet is a worldwide...electronic payments industry that GTX Partners bring to Sysnet," said...officer of NOVA Information Systems, Inc., is managing partner of GTX Partners LLC. Both Grzedzinski...


FDA finds deficiencies in GTx drug
American City Business Journals | 22 days 11 hours 25 minutes ago
Memphis-based GTx Inc. has received a Complete Response Letter from the U.


Cowen Healthcare Royalty Partners Establishes Strategic Advisory Board [Press Release]
PRNewswire | 68 days 16 hours 19 minutes ago
...Partner at SV Life Sciences Advisers LLP and serves as a Non-Executive Director of Micromet Inc., Fulcrum Pharma plc, Santarus, Inc. and GTx, Inc. Previously, Dr. Carter was a member of the Strategic Advisory Board for the Paul Royalty...





 1  2  3  4  5   Next >

67 Results

Sign up for FDLI SmartBrief



Designed specifically for professionals involved in the food and drug industry, FDLI SmartBrief is a FREE daily e-mail newsletter. It provides the latest need-to-know news and industry information that maximizes your time, giving you an edge over your competition. Learn more

Company Overview


Company: GTx, Inc.
Industry: Pharmaceuticals Manufacturers
Website: http://www.gtxinc.com

GTx knows hormones are just as important to men as they are to women. The company develops therapies targeting estrogens and androgens for prostate cancer and other diseases in the arena of men's health. GTx's lead drug candidate, Acapodene, could prevent men who have been identified with certain precancerous conditions from developing prostate cancer. The drug may also be useful in treating osteoporosis, hot flashes, and other side effects of androgen-deprivation therapy (a treatment for advanced prostate cancer). To fund its work, GTx sells Fareston, a drug for metastatic breast cancer. Chairman J.R. Hyde owns nearly one-third of the company.


Key Numbers

Sales in U.S. Dollars (mil.) 13.5 (2008)
One-year % Growth in Sales 89.8 (2008)
Net Income in U.S. Dollars (mil.) -51.8 (2008)
One-year % Growth in Net Income 0.0 (2008)
Number of Employees 147 (2008)
One-year % Growth in Number of Employees 32.4 (2008)
Fiscal Year-End December